CANCER AND METASTASIS REVIEWS 期刊简介
Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive, phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments.
Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition, an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer.
A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease, as well as to highlight new and promising directions, be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative.
当代生物医学研究正处于一个时代的门槛,在这个时代,可以用越来越精确和机械的术语来分析生理和病理过程。生物学从主要是描述性的现象学学科转变为可以理解和控制具有可预测性的调节原理的学科,为癌症的研究和寻找有效的治疗方法带来了新的维度。癌症和转移评论提供了一个论坛,用于对这些具有挑战性的发展进行批判性审查和讨论。
每期癌症和转移评论专门针对特定主题或主题,并将包含五到七个不同的贡献。此外,还包括在要涵盖的领域中与众不同的个人的介绍性前言。主题和贡献者由主编在与编辑顾问委员会的各个成员协商后选择。特别强调与癌症转移和肿瘤进展的分子和细胞生物学以及转移性疾病的治疗相关的主题。偶尔的问题将致力于对特定类型癌症进行深入的临床和生物学分析。
该杂志的主要功能是回顾一些更重要和有趣的最新进展在生物学和恶性疾病的治疗,以及突出新的和有前途的方向,无论是技术上的还是概念上的。鼓励贡献者审查其个人工作并进行投机。
期刊ISSN
|
0167-7659 |
影响指数
|
9.171 |
最新CiteScore值
|
10.70 查看CiteScore评价数据 |
最新自引率
|
1.10% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ |
偏重的研究方向(学科)
|
医学-肿瘤学 |
出版周期
|
Quarterly |
出版年份
|
1982 |
出版国家/地区
|
UNITED STATES |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)2区
是
|
|||||
最新的影响因子
|
9.171 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 134 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
10.70
|
||||||||||||||
年文章数 | 85 | ||||||||||||||
SJR
|
2.555 | ||||||||||||||
SNIP
|
2.139 | ||||||||||||||
CiteScore排名
|
|
||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
INTEGRATIVE CANCER THERAPIES | 3.246 |
Hormones & Cancer | 3.83 |
ENDOCRINE-RELATED CANCER | 5.621 |
Frontiers of Medicine | 4.546 |
Molecular Medicine Reports | 2.922 |
Molecular Therapy-Oncolytics | 7.128 |
American Journal of Translational Research | 4.019 |
BREAST | 4.336 |
Breast Care | 2.831 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
ENDOCRINE-RELATED CANCER | 5.621 |
Molecular Therapy-Oncolytics | 7.128 |
GYNECOLOGIC ONCOLOGY | 5.427 |
ORAL ONCOLOGY | 5.284 |
MOLECULAR CARCINOGENESIS | 4.736 |
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 10.573 |
STEM CELLS | 6.214 |
CANCER GENE THERAPY | 5.927 |
EJSO | 4.38 |
分享者 | 点评内容 |